Evidence supporting the use of: Bifidobacteria
For the health condition: Enteritis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Bifidobacteria, a genus of probiotic bacteria commonly found in the human gut, has been studied for its potential to support or treat enteritis, which is inflammation of the intestine often caused by infection or other irritants. Scientific evidence, primarily from clinical trials and experimental models, suggests that Bifidobacteria can have beneficial effects in managing enteritis, especially when the enteritis is associated with infections or antibiotic-associated diarrhea.

Randomized controlled trials have demonstrated that certain strains of Bifidobacteria, such as Bifidobacterium bifidum and Bifidobacterium lactis, can help reduce the duration and severity of infectious diarrhea in children and adults. Animal models of enteritis (including models induced by pathogenic bacteria or chemical irritants) have shown that administration of Bifidobacteria can reduce intestinal inflammation, improve mucosal barrier function, and modulate immune responses, contributing to faster recovery.

However, while the probiotic use of Bifidobacteria is scientifically supported in the context of infectious diarrhea and antibiotic-associated enteritis, evidence is less robust for other forms of enteritis (e.g., autoimmune or chronic inflammatory types). The overall quality and quantity of evidence is moderate, not definitive, and strain-specific effects are important. Therefore, the use of Bifidobacteria for enteritis is justified by scientific evidence, but more large-scale, high-quality trials are needed to clarify its efficacy and optimal use.

More about Bifidobacteria
More about Enteritis

Products containing Bifidobacteria

We currently have no products on Vitabase that contain this ingredient.